Embleporicin: A New Antimicrobial Peptide from Embleya sp. NF3
Author Information
Author(s): Roblero-Mejía Dora Onely, García-Ausencio Carlos, Rodríguez-Sanoja Romina, Guzmán-Chávez Fernando, Sánchez Sergio
Primary Institution: Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM)
Hypothesis
Can genome mining and cell-free protein synthesis be used to produce a novel antimicrobial peptide from Embleya sp. NF3?
Conclusion
The study successfully identified and produced embleporicin, a novel class I lanthipeptide with antimicrobial activity against Micrococcus luteus.
Supporting Evidence
- Embleporicin is the first RiPP reported in the genus Embleya.
- The peptide demonstrated antimicrobial activity against Micrococcus luteus ATCC 9341.
- Genome mining revealed the genetic potential of Embleya sp. NF3 for producing novel peptides.
- Cell-free protein synthesis was successfully applied to produce embleporicin.
Takeaway
Scientists found a new antimicrobial peptide called embleporicin from a special bacteria, and they made it in the lab without using living cells.
Methodology
The researchers used genome mining and cell-free protein synthesis to identify and produce embleporicin.
Limitations
The production of embleporicin was only detectable at high concentrations of cell-free protein synthesis, indicating potential challenges in yield.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website